{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:08:08Z","timestamp":1784185688234,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204695"],"award-info":[{"award-number":["82204695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbt.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:19:51Z","timestamp":1778761191000},"page":"66-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Organoid transcriptomics identifies IFIT-associated immune modulation during cryptotanshinone treatment for cancer"],"prefix":"10.1016","volume":"94","author":[{"given":"Mengni","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-0213","authenticated-orcid":false,"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nbt.2026.05.006_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.nbt.2026.05.006_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0970-1591.203416","article-title":"Advances in surgical management of muscle invasive bladder cancer","volume":"33","author":"Kukreja","year":"2017","journal-title":"Indian J Urol"},{"issue":"5","key":"10.1016\/j.nbt.2026.05.006_bib4","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib5","doi-asserted-by":"crossref","first-page":"vi45","DOI":"10.1093\/annonc\/mdr376","article-title":"Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Bellmunt","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.23736\/S2724-6051.21.04309-5","article-title":"Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era","volume":"73","author":"Albisinni","year":"2021","journal-title":"Minerva Urol Nephrol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6444","key":"10.1016\/j.nbt.2026.05.006_bib8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson D","year":"2019","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nbt.2026.05.006_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib10","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","article-title":"Bladder cancer organoids as a functional system to model different disease stages and therapy response","volume":"14","author":"Minoli","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.nbt.2026.05.006_bib11","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: A tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.nbt.2026.05.006_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073483","article-title":"Patient-derived organoids as a model for cancer drug discovery","volume":"22","author":"Rae","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbt.2026.05.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111332","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed Pharm"},{"issue":"2","key":"10.1016\/j.nbt.2026.05.006_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7150\/jca.31422","article-title":"Cryptotanshinone inhibites bladder cancer cell proliferation and promotes apoptosis via the PTEN\/PI3K\/AKT pathway","volume":"11","author":"Liu","year":"2020","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib15","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5220","article-title":"Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR\/beta\u2011catenin\/N\u2011cadherin axis","volume":"59","author":"Kim","year":"2021","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BJ20140644","article-title":"STAT2\/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1","volume":"466","author":"Blaszczyk","year":"2015","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.nbt.2026.05.006_bib17","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1073\/pnas.1718426115","article-title":"Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function","volume":"115","author":"Rengachari","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902599","article-title":"Regulation of cGAS-Mediated Immune Responses and Immunotherapy","volume":"7","author":"Saeed","year":"2020","journal-title":"Adv Sci"},{"issue":"Pt A","key":"10.1016\/j.nbt.2026.05.006_bib20","article-title":"Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma","volume":"101","author":"Jiang","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28259","article-title":"The emerging roles of IFIT3 in antiviral innate immunity and cellular biology","volume":"95","author":"Zhang","year":"2023","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.nbt.2026.05.006_bib22","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.18632\/oncotarget.2494","article-title":"Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular \u201cpseudoinflammation\u201d contributing to an aggressive phenotype","volume":"6","author":"Niess H","year":"2014","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.nbt.2026.05.006_bib23","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.7150\/thno.43093","article-title":"Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.nbt.2026.05.006_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","article-title":"Emerging Functions of Human IFIT Proteins in Cancer","volume":"6","author":"Pidugu","year":"2019","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12920-023-01735-0","article-title":"The diagnostic\/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia","volume":"16","author":"Zhao","year":"2023","journal-title":"BMC Med Genom"},{"issue":"25","key":"10.1016\/j.nbt.2026.05.006_bib26","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.2174\/0929867328666210617105209","article-title":"Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer","volume":"28","author":"Tan","year":"2021","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s13402-021-00651-8","article-title":"IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt\/beta-catenin signaling","volume":"44","author":"Li","year":"2021","journal-title":"Cell Oncol"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00432-017-2351-4","article-title":"Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma","volume":"143","author":"Zhao","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-019-1669-z","article-title":"The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression","volume":"10","author":"Huang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A Language for Data Analysis and Graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graph Stat"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s43586-022-00184-w","article-title":"Principal component analysis","volume":"2","author":"Greenacre M","year":"2022","journal-title":"Nat Rev Methods Prim"},{"issue":"12","key":"10.1016\/j.nbt.2026.05.006_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner M","year":"2000","journal-title":"Nat Genet"},{"issue":"Database","key":"10.1016\/j.nbt.2026.05.006_bib34","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"Kanehisa","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.nbt.2026.05.006_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.nbt.2026.05.006_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"issue":"1-27","key":"10.1016\/j.nbt.2026.05.006_bib37","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader G D","year":"2003","journal-title":"BMC Bioinforma"},{"issue":"4","key":"10.1016\/j.nbt.2026.05.006_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.nbt.2026.05.006_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"7738","key":"10.1016\/j.nbt.2026.05.006_bib41","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/s41586-018-0722-x","article-title":"Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"565","author":"Barretina","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2026.05.006_bib42","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.nbt.2026.05.006_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann S","year":"2013","journal-title":"BMC Bioinforma"},{"issue":"4","key":"10.1016\/j.nbt.2026.05.006_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"W1","key":"10.1016\/j.nbt.2026.05.006_bib45","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"10.1016\/j.nbt.2026.05.006_bib46","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"issue":"7873","key":"10.1016\/j.nbt.2026.05.006_bib47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.nbt.2026.05.006_bib48","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nbt.2026.05.006_bib49","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","author":"UniProt","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"10.1016\/j.nbt.2026.05.006_bib50","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.nbt.2026.05.006_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3892\/ijo.2016.3606","article-title":"Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells","volume":"49","author":"Choi","year":"2016","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib53","first-page":"167","article-title":"Puerarin inhibits bladder cancer cell proliferation through the mTOR\/p70S6K signaling pathway","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncol Lett"},{"issue":"17","key":"10.1016\/j.nbt.2026.05.006_bib54","doi-asserted-by":"crossref","first-page":"21251","DOI":"10.18632\/aging.203441","article-title":"Betulinic acid induces autophagy-dependent apoptosis via Bmi-1\/ROS\/AMPK-mTOR-ULK1 axis in human bladder cancer cells","volume":"13","author":"Zhang Y","year":"2021","journal-title":"Aging"},{"issue":"8","key":"10.1016\/j.nbt.2026.05.006_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081616","article-title":"Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling","volume":"18","author":"Huang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbt.2026.05.006_bib56","article-title":"IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.nbt.2026.05.006_bib57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"issue":"7637","key":"10.1016\/j.nbt.2026.05.006_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.nbt.2026.05.006_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.nbt.2026.05.006_bib60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present Yourself! By MHC Class I and MHC Class II Molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"WebServer","key":"10.1016\/j.nbt.2026.05.006_bib62","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nbt.2026.05.006_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coviro.2014.03.006","article-title":"Interferon-stimulated genes: roles in viral pathogenesis","volume":"6","author":"Schoggins","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-Stimulated Genes: What Do They All Do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu Rev Virol"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imr.13300","article-title":"Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research","volume":"322","author":"Asano","year":"2024","journal-title":"Immunol Rev"},{"issue":"21","key":"10.1016\/j.nbt.2026.05.006_bib66","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.nbt.2026.05.006_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14070736","article-title":"The cGAS\/STING Pathway-A New Potential Biotherapeutic Target for Gastric Cancer?","volume":"14","author":"Tian","year":"2024","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00018-024-05214-2","article-title":"When DNA-damage responses meet innate and adaptive immunity","volume":"81","author":"Tong","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nbt.2026.05.006_bib69","article-title":"The cGAS-STING Pathway: Novel Perspectives in Liver Diseases","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nbt.2026.05.006_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.854215","article-title":"Network Pharmacology and Molecular Docking to Elucidate the Potential Mechanism of Ligusticum Chuanxiong Against Osteoarthritis","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Pharm"},{"issue":"5","key":"10.1016\/j.nbt.2026.05.006_bib71","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.eururo.2023.05.011","article-title":"Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection","volume":"84","author":"Meeks","year":"2023","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.nbt.2026.05.006_bib72","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib73","article-title":"Protumorigenic Interferon-Stimulated Genes in Cancer: A Comprehensive Review","volume":"16","author":"Butt","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.nbt.2026.05.006_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061435","article-title":"Clinical Utility of IFIT Proteins in Human Malignancies","volume":"13","author":"Parsyan","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib75","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/s41467-024-50618-0","article-title":"Community assessment of methods to deconvolve cellular composition from bulk gene expression","volume":"15","author":"White","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nbt.2026.05.006_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1237964","article-title":"A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.nbt.2026.05.006_bib77","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1158\/0008-5472.CAN-21-0030","article-title":"Targeting an inducible SALL4-mediated cancer vulnerability with sequential therapy","volume":"81","author":"Yang","year":"2021","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.nbt.2026.05.006_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031217","article-title":"PROTACs in epigenetic cancer therapy: current status and future opportunities","volume":"28","author":"Liu","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.13272","article-title":"Type I interferon and cancer","volume":"321","author":"Holicek","year":"2024","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"issue":"12","key":"10.1016\/j.nbt.2026.05.006_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.nbt.2026.05.006_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J Hematol Oncol"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:02:30Z","timestamp":1784185350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678426000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":82,"alternative-id":["S1871678426000609"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2026.05.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.01.28.702456","asserted-by":"object"}]},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid transcriptomics identifies IFIT-associated immune modulation during cryptotanshinone treatment for cancer","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}